Abstract

This study aimed at determining the causes of failure of the different proposed strategies to ensure improvement of medication-overuse headache (MOH) patients, since they have not been investigated so far, especially with regard to aspects related to cognitive and behavioural aspects of symptomatic drugs overused by them. One hundred and twenty in-patients, 82 females (68.3 %), median age 49 (42–56) years, affected by MOH were admitted to the study and treated with abrupt discontinuation of the medication overused, a 6-day in-patient detoxification regimen and an immediate start of personalized prophylactic treatment, then followed for 1 year. Leeds Dependence Questionnaire (LDQ), among all the clinical variables, was administered at baseline and at 1-year follow-up visit to assess substance dependence. Of the 120 patients enrolled, 68 (56.7 %) were successfully detoxified (Responder-group), while 52 (43.3 %) were not (Non-Responder-group). At baseline, the mean LDQ total score was slightly higher in the Non-Responder group than in the Responder group (12.08 ± 2.14 vs. 11.94 ± 1.98). Although this difference was not significant at baseline (p > 0.05), the LDQ total score was significantly different (p < 0.001) at the 1-year follow-up visit between the responder group (7.8 ± 2.3) and the Non-Responder group (12.1 ± 2.1). Moreover, the pattern of the responses of the patients in the responder group differed from that of the Non-Responder-group in the items relating to the compulsion to start, compulsion to continue, primacy of effect, constancy of state and cognitive set. The results showed that patients of the Non-Responder group showed a drug dependence pattern similar to that previously described in addicts. Conversely, in patients who positively responded to the procedure, drug-abuse behaviour seemed to be a consequence of chronic headache, reflecting the need for daily analgesic use to cope with everyday life.

Highlights

  • Medication-overuse headache (MOH) [1] and its treatment represent the major challenge for a physician in a specialty headache centre

  • The results showed that patients of the Non-Responder group showed a drug dependence pattern similar to that previously described in addicts

  • medication-overuse headache (MOH) diagnosis was made according to ICHD-II modified criteria [6] by two experienced clinicians of our Headache Centre based on a semi-structured clinical interview and a 3-month headache diary

Read more

Summary

Introduction

Medication-overuse headache (MOH) [1] and its treatment represent the major challenge for a physician in a specialty headache centre. J Headache Pain (2012) 13:653–660 consensus concerning withdrawal and detoxification strategies in MOH [10]. The majority of patients report an improvement of headache shortly after withdrawal, long-term studies (involving follow-up periods of up to 6 years) indicate that between 24 and 43 % of them relapse (40 % during the first year after withdrawal) and develop MOH again despite an initially successful withdrawal therapy [8, 11,12,13,14]. According to the International Classification of Headache Disorders (ICHD-II), MOH implies that headache is present on C15 days/month with a regular overuse for [3 months of one or more drugs that can be taken for acute/symptomatic treatment of headache (C10 days/ month for ergotamine, triptans, opioids, combination analgesic medications or combination of acute medications and C15 days/month for analgesics and nonsteroidal antiinflammatory drugs—NSAIDs) [5,6,7].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call